FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
20/08/2023
Voltar para busca
Dado oficial do USPTO
COAPTIUM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
COAPTIUM
ST13
US500000079321619Classe
5, 10, 42, 44
Pedido
79321619
Registro
7033029
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
20/08/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42, 44
Data de depósito
27/05/2021
Data de registro
25/04/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/04/2023
Última transação
25/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
RENNIE, GABRIELLE M
Unidade examinadora
M40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
TISSIUM
Representantes
Pradeep Jayaraman IpHorgan Ltd.
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalsurgicalveterinary preparations for repairing nervesfor cardiovascular treatment; chemical preparations for medicalsurgicalpharmaceutical or veterinary use for nerve repaircardiovascular treatment; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachetspharmaceutical preparations for nerve repair and cardiovascular treatment; capsules made of dendrimer-based polymers sold empty for pharmaceuticalspharmaceutical preparationsa drug delivery system comprising polymer based-oral tablets for the continuous release of a wide variety of therapeutic agents for medicalsurgicalpharmaceuticalveterinary use for nerve repair and cardiovascular treatment; adhesiveglues and sealants for medicalsurgicalpharmaceuticalveterinary use for nerve repair and cardiovascular treatment; biological or chemical preparations for medicalsurgicalpharmaceutical or veterinary use for nerve repair and cardiovascular treatment; diagnostic productsmedical diagnostic test media in the form of strips and medical preparations for medical use for nerve repair and cardiovascular treatment
Classe 10
Medicalsurgical and veterinary apparatus and instruments for nerve repair and cardiovascular treatment; medical devices for nerve repair and cardiovascular treatmentdevice for improving nerve regeneration and repairfor reconnecting and protecting nerves; artificial hipbreastlarynxhand implantsjointhipbreathdentalbone prosthesesartificial vascular graftsconnectorsjointssubstitutes for tendons; suturefasteningartificial repairprotection material for implantsprosthesesgraftstendons; syringes for medical or surgical use and applicators in the nature of syringe barrels for syringes for medical or surgical applications; surgical lamps; medical examination lamps; heating lamps for medical applications
Classe 42
Biological and biochemical research services in the field of nerve repair and cardiovascular applications; scientific and technological research and development serviceschemical and medical chemistry research in the field of nerve repair and cardiovascular applications; research and development services for pharmaceutical products in the field of nerve repair and cardiovascular applications; medical research and clinical studies in the field of nerve repair and cardiovascular applications; quality control services for preparations and products for medical use for nerve repair and cardiovascular applications
Classe 44
Medical services in the field of nerve repair and cardiovascular applications; providing medical information in the field of nerve repair and cardiovascular applications treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/08/2023
FIMP
FINAL DISPOSITION PROCESSED
02/08/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
25/04/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/03/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/03/2023
GPNX
NOTIFICATION PROCESSED BY IB
07/02/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2023
PUBO
PUBLISHED FOR OPPOSITION
07/02/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/01/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/11/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
30/11/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
14/09/2022
GNFR
FINAL REFUSAL E-MAILED
14/09/2022
CNFR
FINAL REFUSAL WRITTEN
14/09/2022
DOCK
ASSIGNED TO EXAMINER
25/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/08/2022
RFNT
REFUSAL PROCESSED BY IB
11/04/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/03/2022
RFRR
REFUSAL PROCESSED BY MPU
21/03/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/02/2022
CNRT
NON-FINAL ACTION WRITTEN
17/02/2022
DOCK
ASSIGNED TO EXAMINER
10/02/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/09/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COAPTIUM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.